Skip to main content
. 2006 Dec 20;60(10):1148–1154. doi: 10.1136/jcp.2006.044842

Table 1 Antibodies used in study with sources, dilutions and methods of pretreatment.

Antibody Source Dilution Pretreatment
AE1/3 Dako (Ely, UK) 1:100 Protease 1 (4 min)
Epithelial membrane antigen Dako 1:10 See materials and methods
Desmin Dako 1:100 See materials and methods
α smooth muscle actin Dako 1:500 See materials and methods
h‐caldesmon Dako 1:50 Pressure cooker 2 min, pH 7.8 buffer; protease 3 (2 min)
α inhibin Dako 1:200 See materials and methods
Calretinin Zymed (San Francisco, CA, USA) 1:50 See materials and methods
Melan A Dako 1:10 See materials and methods
CD99 Dako 1:10 None
Oestrogen receptor (clone sp1) Labvision (Fremont, CA, USA) 1:200 See materials and methods
Progesterone receptor Dako 1:50 See materials and methods
Androgen receptor Novocastra (Newcastle, UK) 1:100 See materials and methods
Vimentin Dako 1:400 See materials and methods
WT1 Dako 1:50 See materials and methods
CD10 Novocastra 1:5 See materials and methods
CD56 Novocastra 1:50 See materials and methods
Chromogranin Dako 1:600 See materials and methods
HMB45 Dako 1:100 See materials and methods